Answers are grounded in this paper and cite their sources.
Laboratory analysis shows significant antibiofilm effects of mango seed extract on E. coli strains, suggesting a potential alternative treatment approach.
The emergence of antimicrobial-resistant bacteria, particularly the extended-spectrum beta-lactamase-Escherichia coli is one of the major health concerns worldwide. Plant extracts offer a promising alternative for such. Mangifera indica L. seed kernel extract (MSKE) contains the com-ponent to fight the bacteria. Seed kernel extract yielded 21% and alkaloids, glycosides, flavonoids, sterols, tannins, and phenols were identified. The concentration of total phenolic content was 47.513 ug/mL. Qualitative biofilm presented 50% strong and 40% weak biofilm formation on the isolates, whereas 70% moderate biofilm formation was detected in more reliable quantitative meth-od. The Minimum Biofilm Inhibition Concentration (MBIC) and Minimum Biofilm Eradication Con-centration (MBEC) were identified and showed that as MSKE concentration decreased, biofilm den-sity decreased. All MSKE concentrations, down to 6.25 mg/mL, significantly inhibited biofilm for-mation compared to negative control (p <0.01). Despite effective, the extract did not match with the strength of antimicrobial drug (positive control). In MBEC, 6.25 mg/mL showed significant biofilm reduction, approaching the positive control’s efficacy. Therefore, Mangifera indica L. seed kernel extract exhibited a promising antibiofilm activity against ESBL-E. coli at low concentration, both inhibition and eradication. Although the antibiofilm activity did not equate with the strength of the established antimicrobial drug, it has the potential to be an alternative treatment for persistent infection. Further in-vivo and synergistic studies are recommended.
No takes yet. Share an insight, caveat, or question.
Corachea et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: